BackJasper Therapeutics- Units (1 Ord Class A & 1/2 War) Overview

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) Receivables

Latest receivables for AMHCU: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) Receivables History

Loading

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) vs. peers: Receivables Comparison

Loading

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) (AMHCU) FAQ

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s receivables stands at $0 as of June 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Jasper Therapeutics- Units (1 Ord Class A & 1/2 War) reported $0 in receivables versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Jasper Therapeutics- Units (1 Ord Class A & 1/2 War)'s receivables evolved across reporting periods, while the comparison chart places AMHCU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.